Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 135 results.
User Information
Export Records
  1. 1.   CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes
  2. Brault, Julie; Liu, Taylor; Bello, Ezekiel; Liu, Siyuan; Sweeney, Colin L.; Meis, Ronald J.; Koontz, Sherry; Corsino, Cristina; Choi, Uimook; Vayssiere, Guillaume; Bosticardo, Marita; Dowdell, Kennichi; Lazzarotto, Cicera R.; Clark, Aaron B.; Notarangelo, Luigi D.; Ravell, Juan C.; Lenardo, Michael J.; Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Wu, Xiaolin; Dahl, Gary A.; Malech, Harry L.; De Ravin, Suk See
  3. Blood. 2021, Dec 30; 138(26): 2768-2780.
  1. 2.   The deubiquitinating enzyme USP37 enhances CHK1 activity to promote the cellular response to replication stress
  2. Stromberg, Benjamin R.; Singh, Mayank; Torres, Adrian E.; Burrows, Amy C.; Pal, Debjani; Insinna, Christine; Rhee, Yosup; Dickson, Andrew S.; Westlake,Christopher; Summers, Matthew K.
  3. The Journal of Biological Chemistry. 2021, Oct; 297(4):
  1. 3.   The epigenetic regulator LSH maintains fork protection and genomic stability via MacroH2A deposition and RAD51 filament formation
  2. Xu,Xiaoping; Ni, Kai; He,Yafeng; Ren, Jianke; Sun, Chongkui; Liu, Yie; Aladjem, Mirit; Burkett, Sandra; Finney, Richard; Ding, Xia; Sharan,Shyam; Muegge,Kathrin
  3. Nature communications. 2021, Jun 10; 12(1):
  1. 4.   Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors
  2. Takebe, Naoko; Naqash, Abdul Rafeh; Coyne, Geraldine O'Sullivan; Kummar, Shivaani; Do, Khanh; Bruns, Ashley; Juwara,Lamin; Zlott, Jennifer; Rubinstein, Larry; Piekarz, Richard; Sharon, Elad; Streicher, Howard; Mittra, Arjun; Miller, Sarah B.; Ji,Jay; Wilsker,Deborah; Kinders,Robert; Parchment,Ralph; Chen,Li; Chang,Ting-Chia; Das,Biswajit; Mugundu, Ganesh; Doroshow, James H.; Chen, Alice P.
  3. CLINICAL CANCER RESEARCH. 2021, Apr 16; 27(14): 3834-3844.
  1. 5.   A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis
  2. Horne, Eric A; Diaz, Philippe; Cimino, Patrick J; Jung, Erik; Xu, Cong; Hamel,Ernest; Wagenbach, Michael; Kumasaka, Debra; Wageling, Nicholas B; Azorín, Daniel D; Winkler, Frank; Wordeman, Linda G; Holland, Eric C; Stella, Nephi
  3. Neuro-oncology advances. 2021, Jan-Dec; 3(1): vdaa165.
  1. 6.   Blood RNA Integrity is a Direct and Simple Reporter of Radiation Exposure and Prognosis: A Pilot Study
  2. Alkhalil, Abdulnaser; Clifford, John L; Ball, Robert; Day, Anna; Chan, Rossana; Carney, Bonnie C; Miller, Stacy Ann; Campbell, Ross; Kumar, Raina; Gautam, Aarti; Hammamieh, Rasha; Moffatt, Lauren T; Shupp, Jeffrey W
  3. Radiation research. 2020, JUN; 193(6): 543-551.
  1. 7.   Elements in the ? Immunity Region Regulate Phage Development: Beyond the "Genetic Switch"
  2. Thomason,Lynn; Morrill, Kathleen; Murray, Gillian; Court,Carolyn; Shafer, Brenda; Schneider,Tom; Court,Don
  3. Molecular microbiology. 2019, DEC; 112(6): 1798-1813.
  1. 8.   Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation
  2. Kinsella, Timothy; Safran, Howard; Wiersma, Susan; DiPetrillo, Thomas; Schumacher, Andrew; Rosati, Kayla; Vatkevich, John; Anderson, Lawrence W.; Hill,Kimberly; Kunos, Charles; Collins,Jerry
  3. CLINICAL CANCER RESEARCH. 2019, Oct 15; 25(20): 6035-6043.
  1. 9.   BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation
  2. Zong, Dali; Adam, Salome; Wang, Yifan; Sasanuma, Hiroyuki; Callen, Elsa; Murga, Matilde; Day, Amanda; Kruhlak, Michael J.; Wong, Nancy; Munro, Meagan; Chaudhuri, Arnab Ray; Karim,Baktiar; Xia, Bing; Takeda, Shunichi; Johnson, Neil; Durocher, Daniel; Nussenzweig, Andre
  3. Molecular cell. 2019, MAR 21; 73(6): 1267-+.
  1. 10.   IFNL4-Delta G Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer
  2. Tang, Wei; Wallace, Tiffany A.; Yi, Ming; Magi-Galluzzi, Cristina; Dorsey, Tiffany H.; Onabajo, Olusegun O.; Obajemu, Adeola; Jordan, Symone V.; Loffredo, Christopher A.; Stephens, Bob; Silverman, Robert H.; Stark, George R.; Klein, Eric A.; Prokunina-Olsson, Ludmila; Ambs, Stefan
  3. CLINICAL CANCER RESEARCH. 2018, Nov 1; 24(21): 5471-5481.
  1. 11.   A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53
  2. Mao, Chao; Wang, Xiang; Liu, Yating; Wang, Min; Jiang, Yiqun; Shi, Ying; Shen, Yi; Liu, Xiaoli; Lai, Weiwei; Yang, Rui; Xiao, Desheng; Cheng, Yan; Liu, Shuang; Zhou, Hu; Cao, Ya; Yu, Weishi; Muegge, Kathrin; Yu, Herbert; Tao, Yongguang
  3. CANCER RESEARCH. 2018, Jul 1; 78(13): 3484-3496.
  1. 12.   LMTK3 confers chemo-resistance in breast cancer
  2. Stebbing, Justin; Shah, Kalpit; Lit, Lei Cheng; Gagliano, Teresa; Ditsiou, Angeliki; Wang, Tingting; Wendler, Franz; Simon, Thomas; Szabo, Krisztina Sara; O'Hanlon, Tim; Dean, Michael; Roslani, April Camilla; Cheah, Swee Hung; Lee, Soo-Chin; Giamas, Georgios
  3. ONCOGENE. 2018, JUN; 37(23): 3113-3130.
  1. 13.   Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk
  2. Barry, K. H.; Koutros, S.; Andreotti, G.; Sandler, D. P.; Burdette, L. A.; Yeager, M.; Freeman, L. E. B.; Lubin, J. H.; Ma, X. M.; Zheng, T. Z.; Alavanja, M. C. R.; Berndt, S. I.
  3. Carcinogenesis. 2012, Feb; 33(2): 331-337.
  1. 14.   CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
  2. Zoppoli, G.; Solier, S.; Reinhold, W. C.; Liu, H.; Connelly, J. W.; Monks, A.; Shoemaker, R. H.; Abaan, O. D.; Davis, S. R.; Meltzer, P. S.; Doroshow, J. H.; Pommier, Y.
  3. Oncogene. 2012, Jan; 31(4): 403-418.
  1. 15.   Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy
  2. Lountos, G. T.; Jobson, A. G.; Tropea, J. E.; Self, C. R.; Zhang, G. T.; Pommier, Y.; Shoemaker, R. H.; Waugh, D. S.
  3. Journal of Structural Biology. 2011, Dec; 176(3): 292-301.
  1. 16.   Genetic Variation in Base Excision Repair Pathway Genes, Pesticide Exposure, and Prostate Cancer Risk
  2. Barry, K. H.; Koutros, S.; Bemdt, S. I.; Andreotti, G.; Hoppin, J. A.; Sandler, D. P.; Burdette, L. A.; Yeager, M.; Freeman, L. E. B.; Lubin, J. H.; Ma, X. M.; Zheng, T. Z.; Alavanja, M. C. R.
  3. Environmental Health Perspectives. 2011, Dec; 119(12): 1726-1732.
  1. 17.   Activation of the c-Jun N-terminal Kinase/Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs
  2. Maciag, A. E.; Nandurdikar, R. S.; Hong, S. Y.; Chakrapan, H.; Diwan, B.; Morris, N. L.; Shami, P. J.; Shiao, Y. H.; Anderson, L. M.; Keefer, L. K.; Saavedra, J. E.
  3. Journal of Medicinal Chemistry. 2011, Nov; 54(22): 7751-7758.
  1. 18.   Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155
  2. Chang, S. H.; Wang, R. H.; Akagi, K.; Kim, K. A.; Martin, B. K.; Cavallone, L.; Haines, D. C.; Basik, M.; Mai, P.; Poggi, E.; Isaacs, C.; Looi, L. M.; Mun, K. S.; Greene, M. H.; Byers, S. W.; Teo, S. H.; Deng, C. X.; Sharan, S. K.; Kathleen Cuningham Fdn, C.
  3. Nature Medicine. 2011, Oct; 17(10): 1275-U308.
  1. 19.   X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket
  2. Lountos, G. T.; Jobson, A. G.; Tropea, J. E.; Self, C. R.; Zhang, G. T.; Pommier, Y.; Shoemaker, R. H.; Waugh, D. S.
  3. Febs Letters. 2011, Oct; 585(20): 3245-3249.
  1. 20.   Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas
  2. Kummar, S.; Chen, A.; Ji, J. P.; Zhang, Y. P.; Reid, J. M.; Ames, M.; Jia, L.; Weil, M.; Speranza, G.; Murgo, A. J.; Kinders, R.; Wang, L. H.; Parchment, R. E.; Carter, J.; Stotler, H.; Rubinstein, L.; Hollingshead, M.; Melillo, G.; Pommier, Y.; Bonner, W.; Tomaszewski, J. E.; Doroshow, J. H.
  3. Cancer Research. 2011, Sep; 71(17): 5626-5634.
  1. 21.   A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay
  2. Biswas, K.; Das, R.; Alter, B. P.; Kuznetsov, S. G.; Stauffer, S.; North, S. L.; Burkett, S.; Brody, L. C.; Meyer, S.; Byrd, R. A.; Sharan, S. K.
  3. Blood. 2011, Sep; 118(9): 2430-2442.
  1. 22.   The Nitric Oxide Prodrug JS-K Is Effective against Non-Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species
  2. Maciag, A. E.; Chakrapani, H.; Saavedra, J. E.; Morris, N. L.; Holland, R. J.; Kosak, K. M.; Shami, P. J.; Anderson, L. M.; Keefer, L. K.
  3. Journal of Pharmacology and Experimental Therapeutics. 2011, Feb; 336(2): 313-320.
  1. 23.   Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
  2. Huang, W. Y.; Yang, P. M.; Chang, Y. F.; Marquez, V. E.; Chen, C. C.
  3. Biochemical Pharmacology. 2011, Feb; 81(4): 510-517.
  1. 24.   Pharmacologic Modulation of Serine/Threonine Phosphorylation Highly Sensitizes PHEO in a MPC Cell and Mouse Model to Conventional Chemotherapy
  2. Martiniova, L.; Lu, J.; Chiang, J.; Bernardo, M.; Lonser, R.; Zhuang, Z. P.; Pacak, K.
  3. Plos One. 2011, Feb; 6(2): 8.
  1. 25.   Targeted JAM-C deletion in germ cells by Spo11-controlled Cre recombinase
  2. Pellegrini, M.; Claps, G.; Orlova, V. V.; Barrios, F.; Dolci, S.; Geremia, R.; Rossi, P.; Rossi, G.; Arnold, B.; Chavakis, T.; Feigenbaum, L.; Sharan, S. K.; Nussenzweig, A.
  3. Journal of Cell Science. 2011, Jan; 124(1): 91-99.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel